Skip to content
Medical Health Aged Care

Estia Health completes acquisition of Robina Rise, Noosa, and Gympie Views residential aged care homes from Calvary Health Care

Estia Health < 1 mins read

MEDIA RELEASE

  • Estia Health strengthens Queensland presence with acquisition
  • No change for residents in the homes
  • Continuity of employment with Estia Health for current employees

 

Estia Health has completed the acquisition of three residential aged care homes previously operated by Calvary Health Care in Robina, Noosa, and Gympie. The homes are now officially owned and operated by Estia Health, expanding the company’s footprint in key Queensland regions.

Sean Bilton, CEO Estia Health said: “We are delighted to be able to increase our commitment to the Sunshine Coast and Gold Coast through the management of an additional 406 residential aged care places, for older Queenslanders.”

“We want to assure all residents and their families that they will continue to receive the same dedicated care and services from the same people that they always have,” Bilton said. “As a provider of residential aged care homes across Australia, we are proud to offer individualised care and support to our residents and their families at an incredibly important time in their lives.”

The acquisition of these three aged care homes reinforces Estia Health’s position as one of Australia’s leading aged care providers, now operating 78 homes nationwide. This expansion demonstrates the company’s ongoing commitment to providing high-quality, person-centred care to older Australians.

Ends

For media enquiries:
Julie Connolly
John Connolly & Partners
[email protected]

 

More from this category

  • CharitiesAidWelfare, Medical Health Aged Care
  • 17/12/2025
  • 06:00
Leukaemia Foundation

Leukaemia Foundation welcomes South Australian Government commitment to establish dedicated CAR T therapy service

The Leukaemia Foundation has welcomed the announcement by theMalinauskas Labor Government that South Australia is establishing a dedicated CAR T-cell therapy service as a line of treatment for people living with blood cancer – marking a major advancement in cancer care in the State. The new service, expected to commence by mid-2026, will significantly improve access to this highly specialised, life-saving treatment and reduce the need for South Australians to travel interstate for care. Leukaemia Foundation Chief Executive Officer Chris Tanti said the announcement represented a huge win for blood cancer patients and their families. “This is a landmark step…

  • Medical Health Aged Care
  • 17/12/2025
  • 01:10
WW International Inc.

Weight Watchers Launches a Fully Integrated Platform for the GLP-1 Era

A redesigned Weight Watchers experience pairs comprehensive GLP-1 support with personalised nutrition, coaching, community support, and cutting-edge technology to help members meet their weight loss goals and achieve results that lastNEW YORK, Dec. 16, 2025 (GLOBE NEWSWIRE) -- WW International, Inc. (NASDAQ: WW) (“Weight Watchers”), the global leader in science-backed weight management, today introduced a new, fully integrated experience bringing together comprehensive support for members on GLP-1 medications, personalised nutrition, behavioural support, coaching, and community within a redesigned app and digital platform. Built for a new era of weight management and long-term health, the new integrated offering delivers coordinated, evidence-based…

  • Medical Health Aged Care
  • 16/12/2025
  • 12:11
Esco Aster Pte. Ltd.

Esco Aster Signs Exosome Clinical cGMP Manufacturing Contract With Shine-On Biomedical For A Novel First-In-Class HLA-G Targeting Exosome Drug Delivery Platform

SINGAPORE–BUSINESS WIRE– Esco Aster, a vertically integrated cell and derivatives CRDMO based at JTC LaunchPad Singapore, announced CMC manufacturing support for Shine-On Biomedical’s HLA-G…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.